Читать книгу Pancreatic Tumors - Группа авторов - Страница 44

1Al-Abbadi MA: Basics of cytology. Avicenna J Med 2011;1:18–28.

2Klapman JB, Logrono R, Dye CE, Waxman I: Clinical impact of on-site cytopathology interpretation on endoscopic ultrasoundguided fine needle aspiration. Am J Gastroenterol 2003;98:1289–1294.

3Hebert-Magee S, Bae S, Varadarajulu S, et al: The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology 2013;24:159–171.

4Schmidt RL, Walker BS, Howard K, Layfield LJ, Adler DG: Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci 2013;58:872–882.

5Haba S, Yamao K, Bhatia V, et al: Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol 2013;48:973–981.

6Collins BT, Murad FM, Wang JF, Bernadt CT: Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures. Cancer Cytopathol 2013;121:518–524.

7Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al: Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011;106:1705–1710.

8Ecka RS, Sharma M: Rapid on-site evaluation of EUS-FNA by cytopathologist: an experience of a tertiary hospital. Diagn Cytopathol 2013;41:1075–1080.

9Chang KJ: Maximizing the yield of EUS-guided fine-needle aspiration. Gastrointest Endosc 2002;56:S28–S34.

10Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T: Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol 2005;40:1013–1023.

11Logrono R, Waxman I: Interactive role of the cytopathologists in EUS-guided fine needle aspiration: an effective approach. Gastrointest Endosc 2001;54:485–490.

12Erickson RA, Sayage-Rabie L, Beissner RS: Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000;51:184–190.

13LeBlanc JK, Ciaccia D, Al-Assi MT, et al: Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004;59:475–481.

14Storch I, Jorda M, Thurer R, et al: Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination. Gastrointest Endosc 2006;64:505–511.

15Lee LS, Nieto J, Watson RR, Hwang AL, Muthusamy VR, Walter L, Jajoo K, Ryou MK, Saltzman JR, Saunders MD, Suleiman S, Kadiyala V: Randomized noninferiority trial comparing diagnostic yield of cytopathologist-guided versus 7 passes for EUS-FNA of pancreatic masses. Dig Endosc 2016;28:469–475.

16Kong F, Zhu J, Kong X, Sun T, Deng X, Du Y, Li Z: Rapid on-site evaluation does not improve endoscopic ultrasound-guided fine needle aspiration adequacy in pancreatic masses: a meta-analysis and systematic review. PLoS One 2016;11:e0163056.

17Thakur M, Guttikonda VR: Modified ultrafast Papanicolaou staining technique: a comparative study. J Cytol 2017;34:149–153.

18de Luna R, Eloubeidi MA, Sheffield MV, Eltoum I, Jhala N, Jhala D, Chen VK, Chhieng DC: Comparison of ThinPrep and conventional preparations in pancreatic fine-needle aspiration biopsy. Diagn Cytopathol 2004;30:71–76.

19Rollins SD, Russell DK: Cytopathology in focus: cell blocks: getting the most from the least invasive method. CAP Today, Aug 2017.

20Balassanian R, Wool GD, Ono JC, Olejnik-Nave J, Mah MM, Sweeney BJ, Liberman H, Ljung BM, Pitman MB: A superior method for cell block preparation for fine-needle aspiration biopsies. Cancer Cytopathol 2016;124:508–518.

21Henwood AF, Charlton A: Extraneous epithelial cells from thromboplastin in cell blocks. Cytopathology 2014;25:412–413.

22Pitman MB, Lewandrowski K, Shen J, Sahani D, Brugge W, Fernandez-del Castillo C. Pancreatic cysts: preoperative diagnosis and clinical management. Cancer Cytopathol. 2010;118(1):1–13.

23Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–32.

24Chai SM, Herba K, Kumarasinghe MP, de Boer WB, Amanuel B, Grieu-Iacopetta F, Lim EM, Segarajasingam D, Yusoff I, Choo C, Frost F: Optimizing the multimodal approach to pancreatic cyst fluid diagnosis: developing a volume-based triage protocol. Cancer Cytopathol 2013;121:86–100.

25Khalid A, McGrath KM, Zahid M, Wilson M, Brody D, Swalsky P, Moser AJ, Lee KK, Slivka A, Whitcomb DC, Finkelstein S: The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005;3:967–973.6.

26Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, Brugge WR, Edmundowicz SA, Hawes RH, McGrath KM: Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095–1102.

27Cizginer S, Turner B, Bilge AR, Karaca C, Pitman MB, Brugge WR: Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40:1024–1028.

28Centeno BA, Stelow EB, Pitman MB (eds): Pancreatic Cytohistology. Cambridge, Cambridge University Press, 2015, chapt 3, p 30.

Dr. Jasreman Dhillon

Moffitt Cancer Center

12902 USF Magnolia Drive

Tampa, FL 33612 (USA)

jasreman.dhillon@moffitt.org